Tag:

Leonard Friedland

Latest Headlines

Latest Headlines

FDA green-lights GSK's MenHibrix

June 21, 2012 | By
The vaccine targets infections with Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B, and is given as four doses between 6 weeks and 18 months of age. Both of these infections can cause meningitis.
Related Tags
Press Releases
  • U.S. FDA Panel Supports Medtronic, Inc. (MDT) Pacemaker
  • Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval
  • FDA APPROVES FIRST OF ITS KIND, FULLY IMPLANTABLE (SURGICALLY), INVISIBLE, PROSTHETIC HEARING RESTORATION DEVICE
  • CryoLife Comments on Status of Medafor Distribution Agreement
  • FDA Statement on Boston Scientific Recall of Implantable Cardioverter Defibrillators
  • More Press Releases
Featured Jobs
  • Clinical Data Manager
    Lexicon Pharmaceuticals -
  • Director/Associate Director, Marketing Analytics
    Lexicon Pharmaceuticals -
  • Vice President, Global Medical Affairs - Multiple Myeloma Job
    Celgene Corporation - Summit NJ US
  • Senior Director, Forecasting Job
    Celgene Corporation - Summit NJ US
  • Senior Director, Translational Development, Hematology / Oncology Job
    Celgene Corporation - San Francisco CA US
Sponsored Links